Primorigen Biosciences' Series A Round

Primorigen Biosciences raised a round of funding on August 07, 2006. Investors include Louisiana Emerging Technology Center.

Primorigen develops, produces and aims to provide technical support for cell therapy research products, including well characterized antibodies, protein targets and microarrays to characterize the dev…

Articles about Primorigen Biosciences' Series A Round: